NetScientific is a transatlantic healthcare IP commercialisation group.
We fund and develop companies that significantly improve the health and well-being of people with chronic diseases.

Board and Management

Sector-specialist senior management team with extensive commercial experience.

  • John Clarkson

    John Clarkson, Non-Executive Chairman of the Group, is an experienced business professional and qualified accountant, who had a successful early career working in various …

    Non-Executive Chairman
  • Dr Ilian Iliev

    Dr. Ilian Iliev, Chief Executive Officer, is Managing Director of EMV Capital, a London-based investor in B2B companies in the industrial high-tech, energy, circular …

    Chief Executive Officer
  • Professor Stephen Smith

    Professor Stephen Smith, Non-Executive Director, joined the NetScientific Board in 2016. Stephen has held senior leadership roles in the NHS and academia. He has …

    Non-Executive Director
  • Stephen Crowe

    Stephen Crowe, CFO, A commercial, growth-focused and highly experienced Finance Leader with over 20+ years of experience in a wide range of financial institutions …

    CFO

News

NetScientific plc (“NetScientific” or the “Company”) PDS Biotechnology Announces Preclinical Data for PDS0203, a T-Cell Activating Recombinant Protein Vaccine Against COVID-19 Versamune-CoV-2 (PDS0203) generated high levels of robust, …

NetScientific plc (“NetScientific” or the “Company”) PDS Biotech Collaborator Granted NIAID Award to Accelerate Development of Versamune®-Based Universal Influenza Vaccine   London, UK – 14 July 2020 – …

NetScientific plc (“NetScientific” or the “Company”) G – Tech Medical, Inc. (“G – Tech”) announces completion of $6.7m Series A financing round led by DigiTx Partners This announcement …

NetScientific healthcare technology group